Exact Sciences (EXAS) Tops Q1 EPS by 3c

Go back to Exact Sciences (EXAS) Tops Q1 EPS by 3c

Mizuho Securities Downgrades Exact Sciences (EXAS) to Neutral

May 4, 2016 6:29 AM EDT

Mizuho Securities downgraded Exact Sciences (NASDAQ: EXAS) from Buy to Neutral with a price target of $6.50 (from $12.00).

Analyst Eric Criscuolo commented, "Were downgrading EXAS from Buy to Neutral and lowering our PT from $12 to $6.50. We now see too much risk to test... More